To: Company Announcements
Date: 25th September 2014
Company: Standard Life Investments Property Income Trust Limited
Subject: Sale of Assets by SLIPIT
Standard Life Investments Property Income Trust is pleased to confirm that it
has exchanged contracts on the sale of two adjacent office buildings in
Chelmsford for £3.5m. The two offices are over rented, with lease expiries in
December 2015. The sale is at the end June valuation figure. Completion is not
due until December 2015, on lease expiry, with the Company retaining all income
to that date.
Jason Baggaley, fund manager of SLIPIT, commented "This transaction is slightly
unusual due to the long delay between exchange and completion, but that means
we have de-risked a lease expiry on a building where cap ex would have been
required whilst maintaining an attractive income stream through to the lease
end. The sale price is at our current valuation, but we will receive a further
£600,000 of income before completion.
All enquiries:
Jason Baggaley
Standard Life Investments Limited
Tel: 0131 245 2833
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.